» Articles » PMID: 21969122

DNA Methyl Transferase 1: Regulatory Mechanisms and Implications in Health and Disease

Overview
Specialty Biochemistry
Date 2011 Oct 5
PMID 21969122
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

DNA methylation serves as the principal form of post-replicative epigenetic modification. It is intricately involved in gene regulation and silencing in eukaryotic cells, making significant contributions to cell phenotype. Much of it is mitotically inherited; some is passed on from one filial generation to the next. Establishment and maintenance of DNA methylation patterns in mammals is governed by three catalytically active DNA methyltransferases - DNMT3a, DNMT3b and DNMT1. While the first two are responsible mainly for de novo methylation, DNMT1 maintains the methylation patterns by preferentially catalyzing S-adenosyl methionine-dependant transfer of a methyl group to cytosine at hemimethylated CpG sites generated as a result of semi-conservative DNA replication. DNMT1 contains numerous regulatory domains that fine-tune associated catalytic activities, deregulation of which is observed in several diseases including cancer. In this minireview, we analyze the regulatory mechanisms of various sub-domains of DNMT1 protein and briefly discuss its pathophysiological and pharmacological implications. A better understanding of DNMT1 function and structure will likely reveal new applications in the treatment of associated diseases.

Citing Articles

Targeting the epigenome with advanced delivery strategies for epigenetic modulators.

Guha S, Jagadeesan Y, Pandey M, Mittal A, Chitkara D Bioeng Transl Med. 2025; 10(1):e10710.

PMID: 39801754 PMC: 11711227. DOI: 10.1002/btm2.10710.


A PDE1 inhibitor, vinpocetine, ameliorates epithelial-mesenchymal transition and renal fibrosis in adenine-induced chronic kidney injury in rats by targeting the DNMT1/Klotho/β-catenin/Snail 1 and MMP-7 pathways.

Abdelfattah A, Mohammed Z, Talaat A, Samy W, Eldesoqui M, Elgarhi R Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39276250 DOI: 10.1007/s00210-024-03393-0.


Mutexa: A Computational Ecosystem for Intelligent Protein Engineering.

Yang Z, Shao Q, Jiang Y, Jurich C, Ran X, Juarez R J Chem Theory Comput. 2023; 19(21):7459-7477.

PMID: 37828731 PMC: 10653112. DOI: 10.1021/acs.jctc.3c00602.


A Porcine DNMT1 Variant: Molecular Cloning and Generation of Specific Polyclonal Antibody.

Zhu L, Wang J, Zhang Y, Xiang X, Liu K, Wei J Genes (Basel). 2023; 14(7).

PMID: 37510229 PMC: 10379332. DOI: 10.3390/genes14071324.


High-throughput computational investigation of protein electrostatics and cavity for SAM-dependent methyltransferases.

Jurich C, Yang Z Protein Sci. 2023; 32(7):e4690.

PMID: 37278582 PMC: 10273352. DOI: 10.1002/pro.4690.


References
1.
Champion C, Guianvarch D, Senamaud-Beaufort C, Jurkowska R, Jeltsch A, Ponger L . Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine. PLoS One. 2010; 5(8):e12388. PMC: 2927531. DOI: 10.1371/journal.pone.0012388. View

2.
El-Osta A, Wolffe A . DNA methylation and histone deacetylation in the control of gene expression: basic biochemistry to human development and disease. Gene Expr. 2000; 9(1-2):63-75. PMC: 5964960. DOI: 10.3727/000000001783992731. View

3.
Robert M, Morin S, Beaulieu N, Gauthier F, Chute I, Barsalou A . DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet. 2002; 33(1):61-5. DOI: 10.1038/ng1068. View

4.
Reik W, Dean W, Walter J . Epigenetic reprogramming in mammalian development. Science. 2001; 293(5532):1089-93. DOI: 10.1126/science.1063443. View

5.
Pradhan M, Esteve P, Chin H, Samaranayke M, Kim G, Pradhan S . CXXC domain of human DNMT1 is essential for enzymatic activity. Biochemistry. 2008; 47(38):10000-9. DOI: 10.1021/bi8011725. View